Neurology Minute
1,922 episodes — Page 5 of 39
Time Course and Severity of Cognitive Changes as a Function of Aβ Positivity and APOE Genotype in Alzheimer Disease - Part 2
In part two of this two-part series, Dr. Stacey Clardy and Casey R. Vanderlip discuss the changes that neurologists should implement in their clinics based on the findings from this study regarding APOE genotype. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213853
Time Course and Severity of Cognitive Changes as a Function of Aβ Positivity and APOE Genotype in Alzheimer Disease - Part 1
In part one of this two part series, Dr. Stacey Clardy and Casey R. Vanderlip discuss what neurologists need to know about how APOE4 and amyloid interact to impact cognitive function. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213853
The Effect of Epilepsy Surgery on Tonic–Clonic Seizures
Dr. Halley Alexander and Dr. Juan Luis Alcala-Zermeno discuss the outcomes of epilepsy surgery, specifically for patients with tonic-clonic seizures. Show references: https://onlinelibrary.wiley.com/doi/10.1111/epi.18243 https://onlinelibrary.wiley.com/doi/full/10.1111/epi.17452 https://directory.libsyn.com/episode/index/id/26286819
Women History Minute - Tilly Edinger
In this episode of the Neurology Minute, Dr. Alison Christy delves into another women's history minute to discuss Tilly Edinger.
August 2025 President Spotlight: Strategizing to reach the AAN's goals
In the August episode of the President's Spotlight, Dr. Jason Crowell and Dr. Natalia Rost discuss the mid-year assessment of AAN's five-year strategic plan. Show reference: https://www.aan.com/about-the-aan/presidents-spotlight
July 2025 Capitol Hill Report: Medicare Physician Fee Schedule
In the third episode of this series, Dr. Andy Southerland discusses the latest Capitol Hill Report, which outlines the 2026 Medicare fee schedule proposal. Stay updated with what's happening on the hill by visiting aan.com/chr. Learn how you can get involved with AAN advocacy.
Medical Student Perspectives on Stigma in FND
Dr. Kathryn Krulisky and Dr. Jordan Garris discuss educational gaps in understanding FND, the impact of stigma on patient care, and the importance of empathy in medical training. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200219
Medical Student Perspectives on Stigma in FND
Dr. Kathryn Krulisky and Dr. Jordan Garris discuss educational gaps in understanding FND, the impact of stigma on patient care, and the importance of empathy in medical training. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200219
A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis
Dr. Shuvro Roy and Dr. Daniel Blockmans discuss the efficacy and safety of upadacitinib as a treatment option for giant-cell arteritis. Show reference: https://www.nejm.org/doi/10.1056/NEJMoa2413449
Updates in Neuroinfectious Diseases - Part 8
In part eight of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss the study findings and the potential impact on clinical practice. Show reference: https://jamanetwork.com/journals/jamaneurology/fullarticle/2824325
Updates in Neuroinfectious Diseases - Part 7
In part seven of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss how to counsel patients about getting care abroad. Show reference: https://academic.oup.com/cid/article/78/6/1554/7280488
Updates in Neuroinfectious Diseases - Part 6
In part six of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss findings from a recent systematic review on pneumococcal meningitis, including the role of corticosteroid, the importance of treatment timing, and emerging adjunctive therapies that may improve patient outcomes. Show reference: https://academic.oup.com/braincomms/article/6/3/fcae131/7644484
Clinical Approach to Dementia Risk in Patients with Parkinson Disease
Dr. Jason Crowell discusses clinical considerations when addressing cognitive concerns in patients with Parkinson disease. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209699 https://directory.libsyn.com/episode/index/id/32642512
Embolic Stroke of Undetermined Source Treated With Antiplatelet Agents or Anticoagulation
Dr. Dan Ackerman and Dr. James Ernest Siegler discuss the complexities of treating ESUS and emphasize the importance of personalized treatment approaches based on individual patient factors. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213876
Updates in Neuroinfectious Diseases - Part 5
In part five of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss the study findings and when clinicians should maintain suspicion for parechovirus. Show reference: https://academic.oup.com/cid/article-abstract/79/6/1479/7726317?redirectedFrom=fulltext
Efficacy of Aerobic Exercise and Coaching on Physical Fitness in Neuromuscular Disease - Part 2
In the second episode of this two-part series, Dr. Justin Abbatemarco and Dr. Eric L. Voorn discuss how to integrate these coaching elements into practice to promote sustainable changes. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213781 https://www.sciencedirect.com/science/article/pii/S0960896625000458?via%3Dihub
July 2025 Capitol Hill Report: Reconciliation Bill
In the second episode of this series, Dr. Andy Southerland discusses the latest Capitol Hill Report, breaking down what a reconciliation bill is and why it matters. Stay updated with what's happening on the hill by visiting aan.com/chr. Learn how you can get involved with AAN advocacy.
Diagnostic Performance of Plasma Biomarkers in the Outpatient Memory Clinic
Dr. Trey Bateman and Dr. Gregg Day discuss the study design, findings, and clinical implications of using plasma biomarkers in real-world patient care. Show reference: https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.70316
Efficacy of Aerobic Exercise and Coaching on Physical Fitness in Neuromuscular Disease - Part 1
In part one of this two-part series, Dr. Justin Abbatemarco and Dr. Eric L. Voorn discuss how exercise remains essential for people with neuromuscular disorders, even amid limited pharmaceutical options and safety concerns. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213781 https://www.sciencedirect.com/science/article/pii/S0960896625000458?via%3Dihub
Updates in Neuroinfectious Diseases - Part 4
In part four of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss enterovirus D68 and the findings presented in this article. Show reference: https://pubmed.ncbi.nlm.nih.gov/39564148/
Updates in Neuroinfectious Diseases - Part 3
In part three of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss when to suspect Oropouche virus and how to test for it. Show reference: https://onlinelibrary.wiley.com/doi/10.1002/ana.27139
hES Cell-Derived Dopaminergic Neurons for Parkinson Disease - Part 2
In the second episode of this two-part series, Dr. Jeff Ratliff and Dr. Claire Henchcliffe discuss how she advises patients and families on the future of stem cell therapy and Parkinson disease. Show reference: https://www.nature.com/articles/s41586-025-08845-y
hES Cell-Derived Dopaminergic Neurons for Parkinson Disease - Part 1
In the first part of this two-part series, Dr. Jeff Ratliff and Dr. Claire Henchcliffe discuss the important lessons learned from these results. Show reference: https://www.nature.com/articles/s41586-025-08845-y
Neurology Residency Training in 2022
Dr. Jason Crowell and Dr. Brian E. Emmert discuss the concept behind the survey and the surprising findings from the survey results. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200221
Updates in Neuroinfectious Diseases - Part 2
In part two of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss the effect of temperature and precipitation on the incidence of West Nile Neuroinvasive Disease. Show reference: https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(24)00318-1/fulltext
Updates in Neuroinfectious Diseases - Part 1
In part one of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss the new global cryptococcal meningitis guidelines. Show reference: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00731-4/abstract
July 2025 President Spotlight: The Role Science Plays
In the July episode of the President's Spotlight, Dr. Jason Crowell and Dr. Natalia Rost discuss the role science plays in what the AAN does. Show reference: https://www.aan.com/about-the-aan/presidents-spotlight
Prehospital Large-Vessel Occlusion Stroke Detection Scales
Dr. Dan Ackerman and Drs. Luuk Dekker and Jasper D. Daems discuss the analysis of various aLVO stroke detection scales to determine which one is the most useful for prehospital triage. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213570
Women History Minute - Mary Lasker
In this episode of the Neurology Minute, Dr. Alison Christy delves into another women's history minute to discuss Mary Lasker.
2025 European Stroke Organization Conference Highlights - Part 3
In the final episode of this three-part series, Dr. Andy Southerland and Dr. Seemant Chaturvedi discuss the PINGS-2 Trial, which was presented at the 2025 European Stroke Organization Conference. Show reference: https://eso-stroke.org/wp-content/uploads/Curtain-Raiser-2-1.pdf
2025 European Stroke Organization Conference Highlights - Part 2
In part two of this three-part series, Dr. Andy Southerland and Dr. Seemant Chaturvedi discuss the OPTIMISTmain Trial, which was presented at the 2025 European Stroke Organization Conference. Show reference: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00549-5/abstract
2025 European Stroke Organization Conference Highlights - Part 1
In part one of this three-part series, Dr. Andy Southerland and Dr. Seemant Chaturvedi discuss the BRIDGE-TNK Trial, which was presented at the 2025 European Stroke Organization Conference. Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2503867
Role of Central Sensitization Syndrome in Patients With Autonomic Symptoms
Dr. Elizabeth Coon and Dr. Peter Novak discuss how central sensitization plays a role in the autonomic symptoms-sings dichotomy and the importance of addressing both conditions for optimal treatment. Show references: https://www.neurology.org/doi/10.1212/CPJ.0000000000200463
Women History Minute - Jean Holowach-Thurston
In this episode of the Neurology Minute, Dr. Alison Christy delves into another women's history minute to discuss Jean Holowach-Thurston.
Acute Symptomatic Seizures During CAR T-Cell Therapy for Hematologic Malignancies - Part 2
In the second installment of this two-part series, Dr. Jeff Ratliff and Dr. Brin E. Freund discuss clinical guidance for managing patients who may experience neurotoxicity from CAR T-cell, with a specific focus on seizure risk. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213535
June 2025 President Spotlight: Advocacy in Neurology
In the June episode of the President's Spotlight, Dr. Jason Crowell and Dr. Natalia Rost discuss advocacy opportunities. Show reference: https://www.aan.com/about-the-aan/presidents-spotlight
Acute Symptomatic Seizures During CAR T-Cell Therapy for Hematologic Malignancies - Part 1
In part one of this two-part series, Dr. Jeff Ratliff and Dr. Brin E. Freund discuss the incidence of acute symptomatic seizures during CAR T-cell therapy. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213535
Electronic Medical Record Alert to Prevent Iatrogenic Interventions in Patients With PNES
Dr. Halley Alexander and Dr. Serena Yin discuss the effectiveness of an electronic medical record best practice alert in preventing iatrogenic interventions for patients with a diagnosis of PNES. Show references: https://www.neurology.org/doi/10.1212/CPJ.0000000000200457
June 2025 Capitol Hill Report
In the first episode of this new series, Dr. Andy Southerland discusses the June updates from the AAN's Capitol Hill Report (CHR). This month's CHR update includes a member story from Dr. José Posas. Stay updated with what's happening on the hill by visiting aan.com/chr. Learn how you can get involved with AAN advocacy.
Inebilizumab in Generalized Myasthenia Gravis
Dr. Aaron Zelikovich discusses a phase 3 trial that looked at the use of inebilizumab in generalized myasthenia gravis. Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2501561
Optic Nerve Imaging - Part 3
In the final installment of this three-part series, Dr. Elizabeth Zollos discusses another important diagnostic tool, visually evoked potentials or VEP.
Patient Perspectives on Antiseizure Medication Discontinuation
Dr. Halley Alexander and Dr. Samuel W. Terman discuss patients' perceived seizure risk, seizure risk tolerance, and risk counseling techniques. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200475
Outpatient Follow-Up With 30-Day Readmission After Epilepsy or Seizure Discharge
Dr. Katie Krulisky and Dr. Leah Blank discuss the impact of outpatient follow-up on readmission rates for older adults with epilepsy or seizures. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213638
Biopsy-Confirmed Small Vessel Primary CNS Vasculitis - Part 3
In the final part of this three-part series, Dr. Justin Abbatemarco and Dr. Sumanth Reddy discuss his team's findings on the treatment approach presented in this paper. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200397
Biopsy-Confirmed Small Vessel Primary CNS Vasculitis - Part 2
In part two of this three-part series, Dr. Justin Abbatemarco and Dr. Sumanth Reddy discuss how patients with amyloid-beta–related angiitis present. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200397
Seizure Action Plans in Pediatric Convulsive Status Epilepticus - Part 2
In the concluding segment of this series, Dr. Halley Alexander and Dr. Coral M. Stredny delve into the essential components of seizure action plans and identify the individuals who should have one. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200449
Seizure Action Plans in Pediatric Convulsive Status Epilepticus - Part 1
In part one of this two-part series, Dr. Halley Alexander and Dr. Coral M. Stredny discuss the importance of seizure action plans and how this might translate into our clinical care. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200449
Clinical Reasoning Series: Intracerebral Hemorrhage and Tortuous Retinal Arterioles
Dr. Nadia Khalil and Dr. Jean Bouchart discuss the diagnostic approach to intracerebral hemorrhage, the causes of cerebral small vessel disease, and the interpretation of biomolecular tests. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209796
Functional Seizures and Driving - Part 3
In the final episode of this three-part series, Dr. Jodie Roberts and Dr. Urs Fisch discuss functional/dissociative seizures and driving risk. Learn more about the Neurology® Practice Current section and fill out the current survey on functional/dissociative seizures and driving.
Functional Seizures and Driving - Part 2
In part two of this three-part series, Dr. Jodie Roberts and Dr. Barbara A. Dworetzky discuss how often seizure-like or seizure-resembling episodes lead to a diagnosis of functional neurologic disorder. Learn more about the Neurology® Practice Current section and fill out the current survey on functional/dissociative seizures and driving.